CITIGROUP INC - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 94 filers reported holding G1 THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$926
-57.5%
643
-26.6%
0.00%
Q2 2023$2,181
-50.8%
876
-47.1%
0.00%
Q1 2023$4,435
-96.7%
1,655
-93.2%
0.00%
Q4 2022$132,514
-91.7%
24,404
-80.8%
0.00%
-100.0%
Q3 2022$1,590,000
+26400.0%
127,309
+10404.0%
0.00%
Q2 2022$6,000
-98.1%
1,212
-97.1%
0.00%
Q1 2022$320,000
-88.3%
42,054
-84.3%
0.00%
-100.0%
Q4 2021$2,728,000
+47.8%
267,173
+94.2%
0.00%0.0%
Q3 2021$1,846,000
-54.7%
137,557
-26.0%
0.00%
-50.0%
Q2 2021$4,076,000
-4.0%
185,801
+5.3%
0.00%
-33.3%
Q1 2021$4,246,000
+2788.4%
176,465
+2062.3%
0.00%
Q4 2020$147,000
+297.3%
8,161
+151.6%
0.00%
Q3 2020$37,000
-93.6%
3,243
-86.4%
0.00%
Q2 2020$577,000
+86.1%
23,798
-15.4%
0.00%
Q1 2020$310,000
-4.6%
28,135
+128.7%
0.00%
Q4 2019$325,000
-47.6%
12,300
-54.8%
0.00%
Q3 2019$620,000
+35.1%
27,197
+81.6%
0.00%
Q2 2019$459,000
+94.5%
14,976
+5.4%
0.00%
Q1 2019$236,000
-89.1%
14,206
-87.4%
0.00%
-100.0%
Q4 2018$2,156,000
+18.6%
112,585
+223.9%
0.00%0.0%
Q3 2018$1,818,000
+87.6%
34,764
+55.9%
0.00%
+100.0%
Q2 2018$969,000
+1209.5%
22,301
+1024.6%
0.00%
Q1 2018$74,000
+105.6%
1,983
+6.4%
0.00%
Q4 2017$36,0001,8630.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
MPM BioImpact LLC 856,798$6,512,0001.75%
CHI Advisors LLC 488,635$3,714,0001.58%
Pinz Capital Management, LP 186,515$1,418,0000.88%
Lombard Odier Asset Management (Switzerland) SA 542,183$4,121,0000.32%
Rhenman & Partners Asset Management AB 316,137$2,403,0000.24%
Birchview Capital, LP 40,000$304,0000.22%
NEEDHAM INVESTMENT MANAGEMENT LLC 160,000$1,216,0000.18%
Tekla Capital Management LLC 423,869$3,221,0000.11%
Golden Green, Inc. 12,152$92,0000.08%
Virtus ETF Advisers LLC 15,188$115,0000.05%
View complete list of G1 THERAPEUTICS INC shareholders